MX9301344A - METHOD FOR PRODUCING CARBOHYDRATES. - Google Patents
METHOD FOR PRODUCING CARBOHYDRATES.Info
- Publication number
- MX9301344A MX9301344A MX9301344A MX9301344A MX9301344A MX 9301344 A MX9301344 A MX 9301344A MX 9301344 A MX9301344 A MX 9301344A MX 9301344 A MX9301344 A MX 9301344A MX 9301344 A MX9301344 A MX 9301344A
- Authority
- MX
- Mexico
- Prior art keywords
- oligosaccharides
- cell adhesion
- produced
- producing carbohydrates
- glcnac
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Amplifiers (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
The invention relates to oligosaccharides with the sequence GalNAc beta (1-4) (Fuc alpha (1-3) GlcNAc. They are produced by incubating Human Kidney 293 cells and isolating the novel oligosaccharides from the peptide produced. oligosaccharides can be used to act as high affinity ligands of certain cell adhesion receptors, and may be used to prevent or reduce cell adhesion and inflammation.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84986892A | 1992-03-12 | 1992-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9301344A true MX9301344A (en) | 1993-09-01 |
Family
ID=25306715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9301344A MX9301344A (en) | 1992-03-12 | 1993-03-11 | METHOD FOR PRODUCING CARBOHYDRATES. |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0565241B1 (en) |
| JP (1) | JP3171506B2 (en) |
| KR (1) | KR930019696A (en) |
| CN (1) | CN1079967A (en) |
| AT (1) | ATE137241T1 (en) |
| AU (1) | AU661762B2 (en) |
| BR (1) | BR9301136A (en) |
| CA (1) | CA2091521A1 (en) |
| CY (1) | CY1947A (en) |
| CZ (1) | CZ39093A3 (en) |
| DE (1) | DE69302317T2 (en) |
| DK (1) | DK0565241T3 (en) |
| ES (1) | ES2088227T3 (en) |
| FI (1) | FI931086A (en) |
| GR (1) | GR3020406T3 (en) |
| HK (1) | HK132396A (en) |
| HU (1) | HUT69613A (en) |
| IL (1) | IL105018A0 (en) |
| MX (1) | MX9301344A (en) |
| NO (1) | NO930890L (en) |
| NZ (1) | NZ247105A (en) |
| YU (1) | YU16993A (en) |
| ZA (1) | ZA931723B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002081723A1 (en) * | 2001-04-02 | 2002-10-17 | Keio University | Process for producing oligosaccharide chain |
| FI20011664A (en) | 2001-08-17 | 2003-02-18 | Carbion Oy | Cancer-specific oligosaccharide sequences and their use |
| US7943763B2 (en) * | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| JP4790271B2 (en) * | 2002-12-26 | 2011-10-12 | 康宏 梶原 | Three-branched sugar chain asparagine derivatives, the sugar chain asparagine, the sugar chain, and methods for producing them |
| JP3884725B2 (en) | 2003-06-03 | 2007-02-21 | 三菱電機株式会社 | Waveguide device |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5009889A (en) * | 1987-12-31 | 1991-04-23 | Oklahoma Medical Research Foundation | Treatment of dysfunctional vascular endothelium using activated protein C |
-
1993
- 1993-03-10 HU HU9300687A patent/HUT69613A/en unknown
- 1993-03-10 NZ NZ247105A patent/NZ247105A/en unknown
- 1993-03-10 CZ CZ93390A patent/CZ39093A3/en unknown
- 1993-03-10 ZA ZA931723A patent/ZA931723B/en unknown
- 1993-03-11 IL IL105018A patent/IL105018A0/en unknown
- 1993-03-11 FI FI931086A patent/FI931086A/en not_active Application Discontinuation
- 1993-03-11 YU YU16993A patent/YU16993A/en unknown
- 1993-03-11 BR BR9301136A patent/BR9301136A/en not_active Application Discontinuation
- 1993-03-11 KR KR1019930003656A patent/KR930019696A/en not_active Application Discontinuation
- 1993-03-11 MX MX9301344A patent/MX9301344A/en not_active Application Discontinuation
- 1993-03-11 AU AU35199/93A patent/AU661762B2/en not_active Ceased
- 1993-03-11 CN CN93104040A patent/CN1079967A/en active Pending
- 1993-03-11 JP JP05056193A patent/JP3171506B2/en not_active Expired - Fee Related
- 1993-03-11 CA CA002091521A patent/CA2091521A1/en not_active Abandoned
- 1993-03-11 NO NO93930890A patent/NO930890L/en unknown
- 1993-03-12 ES ES93301878T patent/ES2088227T3/en not_active Expired - Lifetime
- 1993-03-12 DK DK93301878.0T patent/DK0565241T3/en active
- 1993-03-12 EP EP93301878A patent/EP0565241B1/en not_active Expired - Lifetime
- 1993-03-12 AT AT93301878T patent/ATE137241T1/en not_active IP Right Cessation
- 1993-03-12 DE DE69302317T patent/DE69302317T2/en not_active Expired - Fee Related
- 1993-03-12 CY CY194793A patent/CY1947A/en unknown
-
1996
- 1996-06-12 GR GR960401581T patent/GR3020406T3/en unknown
- 1996-07-18 HK HK132396A patent/HK132396A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3171506B2 (en) | 2001-05-28 |
| IL105018A0 (en) | 1993-07-08 |
| HUT69613A (en) | 1995-09-28 |
| YU16993A (en) | 1996-02-19 |
| CZ39093A3 (en) | 1994-03-16 |
| AU3519993A (en) | 1993-09-16 |
| HU9300687D0 (en) | 1993-05-28 |
| CN1079967A (en) | 1993-12-29 |
| EP0565241A1 (en) | 1993-10-13 |
| CY1947A (en) | 1993-03-12 |
| EP0565241B1 (en) | 1996-04-24 |
| DK0565241T3 (en) | 1996-05-28 |
| GR3020406T3 (en) | 1996-09-30 |
| BR9301136A (en) | 1993-09-28 |
| NO930890D0 (en) | 1993-03-11 |
| CA2091521A1 (en) | 1993-09-13 |
| DE69302317D1 (en) | 1996-05-30 |
| DE69302317T2 (en) | 1996-09-19 |
| HK132396A (en) | 1996-07-26 |
| NO930890L (en) | 1993-09-13 |
| AU661762B2 (en) | 1995-08-03 |
| JPH0625302A (en) | 1994-02-01 |
| NZ247105A (en) | 1994-11-25 |
| ES2088227T3 (en) | 1996-08-01 |
| FI931086A0 (en) | 1993-03-11 |
| FI931086A (en) | 1993-09-13 |
| ATE137241T1 (en) | 1996-05-15 |
| ZA931723B (en) | 1994-09-10 |
| KR930019696A (en) | 1993-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fukuda et al. | Developmental change and genetic defect in the carbohydrate structure of band 3 glycoprotein of human erythrocyte membrane. | |
| Kornfeld et al. | Solubilization and partial characterization of a phytohemagglutinin receptor site from human erythrocytes | |
| AU3066489A (en) | Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore | |
| IT1150682B (en) | PROCEDURE FOR THE PRODUCTION OF SUBSTANCES PRODUCED FROM CELLS, PARTICULARLY OF ANTIBODIES AND SIMILAR | |
| EP0887418A3 (en) | In vivo method of obtaining cell components | |
| AU7575487A (en) | Method for the preparation of proteins with factor VIII activity by microbial host cells; expression, vectors, host cells, antibodies | |
| AU4014589A (en) | The alpha-subunit of the lfa-1 leukocyte adhesion receptor | |
| NO930975L (en) | MOISTURIZING ONE-COMPONENT POLYSILOX COMPOUND | |
| SE8902767D0 (en) | CHEMICAL PROCEDURE | |
| MX9301344A (en) | METHOD FOR PRODUCING CARBOHYDRATES. | |
| DE3580382D1 (en) | MONOCLONAL ANTIBODIES AGAINST ALPHA-2 INTERFERON AND HYBRIDOMAS PRODUCING SUCH ANTIBODIES. | |
| Roos et al. | Characterization of the oligosaccharide units of the fourth component of complement (Ss protein) synthesized by murine macrophages. | |
| WO1990007321A3 (en) | Lymphocyte receptor homing sequences and their uses | |
| IT8567141A0 (en) | PROCEDURE FOR THE CULTURE OF CELLS BY GAS DISPERSION | |
| BR8904681A (en) | A LINE OF HYBRIDOMA CELLS, MUTANTS, ANTIBODIES, PROCESSES FOR THE PREPARATION OF A CELL LINE AND FOR THE PREPARATION OF ANTIBODIES AND PROCESS AND AGENT FOR IMMUNOLOGICAL PROVENATION OF ATRAZIN | |
| Kato et al. | Characterization of a highly glycosylated biosynthetic intermediate of ovalbumin | |
| RU93004705A (en) | OLIGOSACCHARIDES, PHARMACEUTICAL COMPOSITION, APPLICATION OF OLIGOSACCHARIDES | |
| HUP9901131A2 (en) | P-selectin ligands and related molecules and methods | |
| CHUA | AN INVESTIGATION ON THE SURFACE PROPERTIES OF EMBRYONAL CARCINOMA CELLS: FUNCTIONAL AND STRUCTURAL CORRELATIONS TO EARLY EMBRYOS (GLYCOPROTEINS, PREIMPLANTATION, MOUSE) | |
| McKeown-Longo et al. | Characterization of the tissue-specific proteoglycans synthesized by chondrocytes from nanomelic chick embryos. | |
| NAKAJO et al. | Cell surface radiolabeling of the carbohydrate moieties of the plasma membrane major glycoprotein of AH-66 hepatoma ascites cells | |
| Takahama et al. | Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and-stimulating activity. | |
| ES523050A0 (en) | METHOD OF ISOLATING CELLS RESULTING FROM MERGING MALIGNANT HUMAN CELLS WITH OTHER HUMAN CELLS PROTECTING LYMPHOCINES OR SPECIFIC ANTIBODIES. | |
| IT1125878B (en) | METHOD FOR THE INSTALLATION OF SERVICE PIPES IN FURNITURE, PARTICULARLY FOR CHEMICAL LABORATORIES AND FURNITURE OBTAINED FROM THIS METHOD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |